Angiotesin II Levels, Genetic Polymorphism of Its Receptor AGTR1 and Type 2 Diabetes Mellitus as Functionally Linked Risk Factors for the Development of Septic Shock in Patients with Sepsis

A drop in blood pressure and the development of circulatory failure significantly influences the course and outcome of septic shock (SS). The administration of angiotensin II prevents further progression of shock and organ failure. However, the high clinical heterogeneity of patients and the lack of prognostic markers for identifying high‑risk groups make it impossible to target the specific subgroups for which this approach could be most effective in reducing mortality. Comorbidities and genetic variability affecting responses to vasopressors appear to be the most promising sources of such markers. Study objective. To determine the combined contribution of angiotensin II levels and a functionally linked marker the AGTR1 gene allelic variant rs275651 to the development of septic shock in patients with sepsis, including an analysis that accounts for diabetes mellitus. Materials and methods. The pilot study included patients ( n = 228) aged 18–98 years with clinical signs of sepsis from intensive care units of three Moscow hospitals. AGTR1 rs275651 variants were determined using polymerase chain reaction. Plasma angiotensin II concentrations were measured using enzyme‑linked immunosorbent assay. Results. In the cohort of examined patients, angiotensin II concentration was not associated with the risk of developing SS ( p = 0.068, ROC analysis, n =228). However, for patients with the major AGTR1 rs275651 TT genotype, this association was significant ( p = 0.043, ROC analysis, n =153). No association between angiotensin II concentration and the development of SS was found in carriers of the minor AGTR1 rs275651 A allele (TA and AA genotypes) ( p = 0.84, n =75). Upon stratification into 4 groups based on the presence of diabetes and the AGTR1 rs275651 genotype, it was found that the association between decreased angiotensin II levels and the risk of developing SS persisted only in patients with diabetes and the AGTR1 rs275651 TT genotype. For the remaining three groups (with various genotypes, both with and without diabetes), no association was found between angiotensin II concentration and the development of SS. Conclusion. Reduced angiotensin II (below 124 pg/mL) levels are associated with an adverse course of sepsis and development of septic shock. The significance of this association across the entire cohort is driven by a significant association found in the sub-cohort of patients with type II diabetes mellitus who are homozygous carriers of the major TT genotype of the AGTR1 rs275651.

Authors

Institutions

Publication Details

Journal
General Reanimatology
Published
2026-11-13
DOI
https://doi.org/10.15360/1813-9779-2026-5-2732
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Angiotesin II Levels, Genetic Polymorphism of Its Receptor AGTR1 and Type 2 Diabetes Mellitus as Functionally Linked Risk Factors for the Development of Septic Shock in Patients with Sepsis

Д. Л. Фетлам, А. Г. Чумаченко, A. V. Ilyichev, В. М. Писарев et al.
General Reanimatology
Sepsis Diagnosis and Treatment
article

Angiotesin II Levels, Genetic Polymorphism of Its Receptor AGTR1 and Type 2 Diabetes Mellitus as Functionally Linked Risk Factors for the Development of Septic Shock in Patients with Sepsis

Д. Л. Фетлам, А. Г. Чумаченко, A. V. Ilyichev, В. М. Писарев, E. K. Grigoriev
article en

Abstract

A drop in blood pressure and the development of circulatory failure significantly influences the course and outcome of septic shock (SS). The administration of angiotensin II prevents further progression of shock and organ failure. However, the high clinical heterogeneity of patients and the lack of prognostic markers for identifying high‑risk groups make it impossible to target the specific subgroups for which this approach could be most effective in reducing mortality. Comorbidities and genetic variability affecting responses to vasopressors appear to be the most promising sources of such markers. Study objective. To determine the combined contribution of angiotensin II levels and a functionally linked marker the AGTR1 gene allelic variant rs275651 to the development of septic shock in patients with sepsis, including an analysis that accounts for diabetes mellitus. Materials and methods. The pilot study included patients ( n = 228) aged 18–98 years with clinical signs of sepsis from intensive care units of three Moscow hospitals. AGTR1 rs275651 variants were determined using polymerase chain reaction. Plasma angiotensin II concentrations were measured using enzyme‑linked immunosorbent assay. Results. In the cohort of examined patients, angiotensin II concentration was not associated with the risk of developing SS ( p = 0.068, ROC analysis, n =228). However, for patients with the major AGTR1 rs275651 TT genotype, this association was significant ( p = 0.043, ROC analysis, n =153). No association between angiotensin II concentration and the development of SS was found in carriers of the minor AGTR1 rs275651 A allele (TA and AA genotypes) ( p = 0.84, n =75). Upon stratification into 4 groups based on the presence of diabetes and the AGTR1 rs275651 genotype, it was found that the association between decreased angiotensin II levels and the risk of developing SS persisted only in patients with diabetes and the AGTR1 rs275651 TT genotype. For the remaining three groups (with various genotypes, both with and without diabetes), no association was found between angiotensin II concentration and the development of SS. Conclusion. Reduced angiotensin II (below 124 pg/mL) levels are associated with an adverse course of sepsis and development of septic shock. The significance of this association across the entire cohort is driven by a significant association found in the sub-cohort of patients with type II diabetes mellitus who are homozygous carriers of the major TT genotype of the AGTR1 rs275651.

General ReanimatologyVol. 22(5)
V.A. Negovsky Scientific Research Institute of General Reanimatology (RU), City Clinical Hospital (RU), City Clinical Hospital No15 named. O. M. Filatova (RU), Research Institute of Human Morphology (RU)
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon